Sort
82,697 grants matching “vaccine development”
COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3 - AUGUST 10, 2025 - AUGUST 9, 2026
$9,292,344Lee S Newman · National Jewish Health · N01 · FY2025 · HL
Bioterrorism: Molecular Analysis and Intervention
$9,287,804University Of Chicago · U54 · FY2005 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$9,232,051Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2002 · CA
Abramson Cancer Center Support Grant
$9,230,603Robert H Vonderheide · University Of Pennsylvania · P30 · FY2024 · CA
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$9,214,781Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2020 · AI
Development of Mutivalent Filovirus (Ebola and Marburg) Vaccines
$9,210,189Javad Aman · Integrated Biotherapeutics, Inc. · N01 · FY2010 · AI
CANCER AND LEUKEMIA GROUP B
$9,201,879University Of Chicago · U10 · FY2000 · CA
Acute HIV-1 Infections Network Core
$9,171,891Myron S Cohen · Duke University · U19 · FY2007 · AI
Northeast Biodefense Center
$9,168,492W. Ian Lipkin · Wadsworth Center · U54 · FY2008 · AI
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTG
$9,139,655David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2012 · AI
Defense against Biowarfare and Emerging Infection Agents
$9,124,674University Of Maryland Baltimore · U54 · FY2004 · AI
Northeast Biodefense Center
$9,121,122W. Ian Lipkin · Wadsworth Center · U54 · FY2007 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines
$9,113,435Sukjoon Park · Emergent Product Development Gaithersbur · N01 · FY2010 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE
$9,112,616Matthew Johnson · Duke University · N01 · FY2022 · AI
Structure-based design of broadly protective coronavirus vaccines
$9,065,441Neil King · University Of Washington · P01 · FY2022 · AI
CCR Dedicated Cores
$9,056,475Robin Winkler Pickett · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Phase I HIV vaccine trial with DNAALVAC-HIV gp120 delta V1 vaccines
$9,055,951Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Middle Atlantic Regional Center for Excellence for Biodefense and Emerging Infect
$9,047,135Myron Max Levine · University Of Maryland Baltimore · U54 · FY2010 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$9,040,833Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2003 · CA
Abramson Cancer Center Support Grant
$9,040,646Robert H Vonderheide · University Of Pennsylvania · P30 · FY2023 · CA
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) - DOC
$9,039,091Donald Robert Harris · Westat, Inc. · U01 · FY2015 · HD
Defense against Biowarfare and Emerging Infection Agents
$9,038,291Myron Max Levine · University Of Maryland Baltimore · U54 · FY2008 · AI
SDMC - IMPAACT Leadership Group
$9,033,216David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2014 · AI
Adol. Medicine Trials Network for HIV/AIDS Interventions
$9,023,792James J Korelitz · Westat, Inc. · U01 · FY2009 · HD
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise
$9,020,953David H Walker · University Of Texas Med Br Galveston · U54 · FY2009 · AI